Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation
Objectives: There is renewed interest in targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) for treatment of obesity and type 2 diabetes. G-protein coupled receptor desensitisation is suggested to reduce the long-term efficacy of glucagon-like-peptide 1 receptor (GLP-1R) agon...
Saved in:
Main Authors: | Iona Davies, Alice E. Adriaenssens, William R. Scott, David Carling, Kevin G. Murphy, James S. Minnion, Stephen R. Bloom, Ben Jones, Tricia M-M. Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877825000018 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A lipidated peptide derived from the C-terminal tail of the vasopressin 2 receptor shows promise as a new β-arrestin inhibitor
by: Rebecca L. Brouillette, et al.
Published: (2025-02-01) -
Molecular Vibration-Activity Relationship in the Agonism of Adenosine Receptors
by: Hyun Keun Chee, et al.
Published: (2013-12-01) -
Hormone Receptors in Cervicovaginal Cells
by: Şayeste Demirezen, et al.
Published: (2013-04-01) -
GPCRs in hypothalamic neurons and their roles in controlling food intake and metabolism
by: Tian Qiu, et al.
Published: (2025-02-01) -
Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
by: Alexander C. Martins, et al.
Published: (2024-04-01)